- E-postyaping.hua@uib.no
- BesøksadresseHaukeland universitetssykehus, Laboratoriebygget5009 Bergen
- PostadressePostboks 78045020 Bergen
Vitenskapelig artikkel
- (2022). Proteasome‐mediated regulation of GATA2 expression and androgen receptor transcription in benign prostate epithelial cells. Biomedicines. 14 sider.
- (2022). Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain. Frontiers in Pharmacology. 15 sider.
- (2018). Dual androgen receptor (AR) and STAT3 inhibition by a compound targeting the AR amino-terminal domain. Pharmacology Research & Perspectives. 1-15.
- (2017). An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells. PLOS ONE. 1-20.
- (2016). Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. BMC Cancer. 15 sider.
- (2013). Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling. Cancer Research. 7090-7100.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
- (2017). Models of Tumor Progression in Prostate Cancer. 16 sider.
Poster
- (2022). Robust production of potent dendritic cells for cancer immunotherapy.
- (2022). Robust and potent dendritic cells for cancer immunotherapy.
- (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization.
- (2022). Novel STAT3 inhibitors targeting the STAT3 dimerization.
- (2022). FLT3L and GM-CSF improve conventional dendritic cell viability and function.
- (2020). Novel STAT3 inhibitors targeting STAT3 dimerization by binding to STAT3 SH2 domain.
- (2013). Reactive oxygen species induce prostate cancer cells via activation of the IL6/STAT3 pathway. Abstract 304.
Faglig kapittel
- (2022). Models of Tumor Progression in Prostate Cancer. 453-466. I:
- (2022). Biomarkers of the Tumor Microenvironment. Springer.